The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant icotinib of 12 months or 6 months versus observation following adjuvant chemotherapy for resected EGFR-mutated stage II–IIIA non-small-cell lung cancer (ICTAN, GASTO1002): A randomized phase 3 trial.
 
Si-Yu Wang
No Relationships to Disclose
 
Hao Long
No Relationships to Disclose
 
Ning Li
No Relationships to Disclose
 
Chao Cheng
No Relationships to Disclose
 
Wei Ou
No Relationships to Disclose
 
Lin Yang
No Relationships to Disclose
 
Jian You
No Relationships to Disclose
 
Yi Liang
No Relationships to Disclose
 
Bao-Xiao Wang
No Relationships to Disclose